Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer

Sarah J Counts; Anthony W Kim

doi:10.1016/j.suc.2017.03.012

Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer

Surg Clin North Am. 2017 Aug;97(4):733-750. doi: 10.1016/j.suc.2017.03.012.

Authors

Sarah J Counts¹, Anthony W Kim²

Affiliations

¹ Cardiothoracic Surgery, Yale-New Haven Hospital, Yale School of Medicine, 330 Cedar Street, BB 205, New Haven, CT 06520, USA. Electronic address: sarah.counts@yale.edu.
² Division of Thoracic Surgery, Department of Surgery, Keck School of Medicine, University of Southern California, 1510 San Pablo Street, Suite 514, Los Angeles, CA 90033, USA.

PMID: 28728712
DOI: 10.1016/j.suc.2017.03.012

Abstract

Modalities to detect and characterize lung cancer are generally divided into those that are invasive [endobronchial ultrasound (EBUS), esophageal ultrasound (EUS), and electromagnetic navigational bronchoscopy (ENMB)] versus noninvasive [chest radiography (CXR), computed tomography (CT), positron emission tomography (PET), and magnetic resonance imaging (MRI)]. This chapter describes these modalities, the literature supporting their use, and delineates what tests to use to best evaluate the patient with lung cancer.

Keywords: Chest radiograph; Computed tomography; Endobronchial ultrasound; Esophageal ultrasound; MRI; Navigational bronchoscopy; PET.

Publication types

Review

MeSH terms

Bronchi
Endosonography* / methods
Humans
Lung Neoplasms / diagnostic imaging*
Lung Neoplasms / pathology
Neoplasm Staging
Positron Emission Tomography Computed Tomography*
Practice Guidelines as Topic
Thoracic Diseases / diagnostic imaging*